Kramer Levin Naftalis & Frankel LLP
Christine Willgoos litigates patent actions on behalf of pharmaceutical and biotechnology companies, leading trial and appellate teams in Hatch-Waxman and biologic drug litigation, often involving blockbuster drugs. Ms. Willgoos is an accomplished courtroom advocate with significant experience, including trials and appeals, preliminary injunctions, oral arguments and Markman hearings. She currently represents clients in cases concerning immunoassay technology, cancer drugs and multiple sclerosis drugs.
In addition to litigation, Ms. Willgoos counsels clients in business and legal matters relating to patent portfolios, including antitrust, patent prosecution, life cycle management and regulatory issues.